Community Practice Connections™: Bridging the Gap in Multiple Sclerosis—A Focus on Clinical and Health Care Disparities in Racial-Ethnic Patient Populations
April 12, 2022
April 12, 2023
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by educational grants from Biogen and Sanofi Genzyme.
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
- Nurses — 1.0 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
This educational activity is directed toward neurologists, MS subspecialists, nurse practitioners, physician assistants, registered nurses and other health care professionals involved in the management of patients with MS.
Disparities in health care disproportionally affect members of underserved or underrepresented racial and ethnic backgrounds, limiting access to care and health outcomes. The multiple sclerosis (MS) community is not immune to this challenge. Data indicates variation in the age of onset and disease course for MS patients having African American, Hispanic American, or Asian American ethnicity, which may be related to biological and/or socioeconomic factors. Reducing barriers to care and improving the cultural competency of healthcare professionals is needed to limit the impact of disparities, particularly for patients with MS belonging to these groups.
This Community Practice Connections™ program provides an in-depth review of some of the key highlights from the February 2022 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with MS from diverse backgrounds, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.
Upon completion of this activity, participants should be better able to:
- Evaluate the clinical presentation of MS in racial-ethnic populations
- Analyze the most current data regarding optimal management of MS in racial-ethnic populations
- Integrate elements of cultural competency for optimal management of racial-ethnic populations with MS
- Describe the effect of COVID-19 on healthcare disparities and worsening patient outcomes in racial-ethnic populations with MS
Victor M. Rivera, MD, FAAN
Distinguished Emeritus Professor of Neurology
Founding Director of the Maxine Mesinger Multiple Sclerosis Clinic
Baylor College of Medicine
Robert K. Shin, MD
Professor of Neurology
Georgetown Multiple Sclerosis and Neuroimmunology Center
MedStar Georgetown University Hospital
Mitzi Joi Williams, MD
Neurologist and Multiple Sclerosis Specialist
Founder and Medical Director
Joi Life Wellness Group
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
Victor M. Rivera, MD, FAAN, has no relevant financial relationships with ineligible companies.
- Robert K. Shin, MD
- Grant/Research Support: Genentech
- Consultant: Bristol Myers Squibb, Biogen, Sanofi Genzyme, Novartis, Mallinckrodt Pharmaceuticals, EMD Serono
- Speakers Bureau: Alexion Pharmaceuticals, Horizon Therapeutics, TG Therapeutics, Genentech
- Mitzi Joi Williams, MD
- Grant/Research Support: Biogen, Novartis, Janssen
- Consultant: AbbVie, Alexion, Bristol Myers Squibb, Biogen, Genzyme, Genentech, Novartis, TG Therapeutics
- Speakers Bureau: Bristol Myers Squibb, Novartis, Janssen Pharmaceuticals, Genentech, Genzyme, Biogen
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.